These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 28915117)

  • 1. Molecular genetic and clinical delineation of 22 patients with congenital hypogonadotropic hypogonadism.
    Aoyama K; Mizuno H; Tanaka T; Togawa T; Negishi Y; Ohashi K; Hori I; Izawa M; Hamajima T; Saitoh S
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1111-1118. PubMed ID: 28915117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the mutational spectrum of monogenic hypogonadotropic hypogonadism: novel mutations in ANOS1 and FGFR1 genes.
    Gach A; Pinkier I; Szarras-Czapnik M; Sakowicz A; Jakubowski L
    Reprod Biol Endocrinol; 2020 Jan; 18(1):8. PubMed ID: 31996231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the genetic spectrum of ANOS1 mutations in patients with congenital hypogonadotropic hypogonadism.
    Gonçalves CI; Fonseca F; Borges T; Cunha F; Lemos MC
    Hum Reprod; 2017 Mar; 32(3):704-711. PubMed ID: 28122887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GnRH Deficient Patients With Congenital Hypogonadotropic Hypogonadism: Novel Genetic Findings in
    Neocleous V; Fanis P; Toumba M; Tanteles GA; Schiza M; Cinarli F; Nicolaides NC; Oulas A; Spyrou GM; Mantzoros CS; Vlachakis D; Skordis N; Phylactou LA
    Front Endocrinol (Lausanne); 2020; 11():626. PubMed ID: 32982993
    [No Abstract]   [Full Text] [Related]  

  • 5. The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients.
    Marcos S; Sarfati J; Leroy C; Fouveaut C; Parent P; Metz C; Wolczynski S; Gérard M; Bieth E; Kurtz F; Verier-Mine O; Perrin L; Archambeaud F; Cabrol S; Rodien P; Hove H; Prescott T; Lacombe D; Christin-Maitre S; Touraine P; Hieronimus S; Dewailly D; Young J; Pugeat M; Hardelin JP; Dodé C
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2138-43. PubMed ID: 25077900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of congenital hypogonadotropic hypogonadism in Denmark.
    Tommiska J; Känsäkoski J; Christiansen P; Jørgensen N; Lawaetz JG; Juul A; Raivio T
    Eur J Med Genet; 2014 Jul; 57(7):345-8. PubMed ID: 24732674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.
    Laitinen EM; Tommiska J; Sane T; Vaaralahti K; Toppari J; Raivio T
    PLoS One; 2012; 7(6):e39450. PubMed ID: 22724017
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zeng W; Li J; Wang X; Jiang F; Men M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):847-857. PubMed ID: 36039580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.
    Barraud S; Delemer B; Poirsier-Violle C; Bouligand J; Mérol JC; Grange F; Higel-Chaufour B; Decoudier B; Zalzali M; Dwyer AA; Acierno JS; Pitteloud N; Millar RP; Young J
    Neuroendocrinology; 2021; 111(1-2):99-114. PubMed ID: 32074614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallmann syndrome in women: from genes to diagnosis and treatment.
    Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
    Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome.
    Jongmans MC; van Ravenswaaij-Arts CM; Pitteloud N; Ogata T; Sato N; Claahsen-van der Grinten HL; van der Donk K; Seminara S; Bergman JE; Brunner HG; Crowley WF; Hoefsloot LH
    Clin Genet; 2009 Jan; 75(1):65-71. PubMed ID: 19021638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Kim HG; Kurth I; Lan F; Meliciani I; Wenzel W; Eom SH; Kang GB; Rosenberger G; Tekin M; Ozata M; Bick DP; Sherins RJ; Walker SL; Shi Y; Gusella JF; Layman LC
    Am J Hum Genet; 2008 Oct; 83(4):511-9. PubMed ID: 18834967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital hypogonadotropic hypogonadism and Kallmann syndrome in males].
    Ghervan C; Young J
    Presse Med; 2014 Feb; 43(2):152-61. PubMed ID: 24456696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
    Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
    Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.
    Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC
    Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical genetics of Kallmann syndrome.
    Dodé C; Hardelin JP
    Ann Endocrinol (Paris); 2010 May; 71(3):149-57. PubMed ID: 20362962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations.
    Salenave S; Chanson P; Bry H; Pugeat M; Cabrol S; Carel JC; Murat A; Lecomte P; Brailly S; Hardelin JP; Dodé C; Young J
    J Clin Endocrinol Metab; 2008 Mar; 93(3):758-63. PubMed ID: 18160472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional mutation in
    Ichioka K; Yoshikawa T; Kimura H; Saito R
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.
    Bry-Gauillard H; Trabado S; Bouligand J; Sarfati J; Francou B; Salenave S; Chanson P; Brailly-Tabard S; Guiochon-Mantel A; Young J
    Ann Endocrinol (Paris); 2010 May; 71(3):158-62. PubMed ID: 20363464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.